ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 700893 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 700893; 2) Community: the network communities that were significantly associated with the response to NSC 700893; 3) Molecule: the relationships between components within communities and NSC 700893; 4) MDR: the compounds that were significantly associated with the NSC 700893.

NSC Compound Enrichment Correlation
NSC 357704 Cyanomorpholinodoxorubicin 0.0422011701988039 -0.18391863
NSC 381867 BAFILOMYCIN ANTIBIOTIC 0.0422011701988039 0.0043117722
NSC 615035 Tetrazolium, 1-(4,5-dimethyl-2-thiazolyl)-2-phenyl-4-(4-pyridyl)-,bromide 0.0422011701988039 -0.13409417
NSC 622579 Carbamimidothioic acid, N,N-dimethyl-N'-[(phenylimino) (methylthio)methyl]-, phenylmethyl ester, hydroiodide 0.0422011701988039 -0.27056748
NSC 637220 cis-Difluorobis(1-phenylhexane-1,3-dionato)titanium(IV) 0.0422011701988039 -0.29273301
NSC 641239 Null 0.0422011701988039 -0.17940878
NSC 652173 Null 0.0422011701988039 -0.0060095306
NSC 653864 Null 0.0422011701988039 -0.035505409
NSC 657446 Thiazolo[2,3-b]thiazolium, 2,3-dihydro- 2-[(2-methoxyphenyl)methylene]- 5-(3-nitrophenyl)-3-oxo-, chloride 0.0422011701988039 -0.26026812
NSC 681636 Camptothecin Derivative 0.0422011701988039 -0.1143001
Total:60  Current:43    [First] [Prev] [Next] [Last]